Minicircle
Los Angeles
About Minicircle
Minicircle develops a human genetic enhancement platform to facilitate life extension capabilities. Its platform uses expressive DNA mini circles to add genes to the human body without altering its pre-existing genome that lets healthcare practitioners to relieve suffering and enrich the condition through means of developing and delivering safe, accessible gene therapy. The company was founded in 2019 and is headquartered in Los Angeles, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $458.5K
- Funding stage: Seed
- Last round: Seed (Oct 2021)
- Website: minicircle.org
Industries & Categories
Biotechnology, Genetics, Life Science
Canonical: https://fsome.com/organization/minicircle-137949 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.